Sotagliflozin Suppliers & Bulk Manufacturers
Available Forms: Tablets
Available Strengths: 200 mg, 40mg
Reference Brands: Inpefa (USA), Zynquista (EU)
Category: Diabetes
Sotagliflozin is an oral dual SGLT-1 and SGLT-2 inhibitor that helps lower blood glucose and reduces the risk of heart-failure related events. It is used in adults with type 2 diabetes and those with heart failure to improve cardiovascular outcomes. Sotagliflozin is available in Tablets and strengths such as 200 mg, 40mg. Sourced from GMP-certified and ISO-compliant manufacturers, this API meets global pharmacopeia standards (USP/EP/JP as applicable). Ideal for pharmaceutical formulation and commercial manufacturing, Sotagliflozin is supplied in bulk quantities with complete regulatory support including DMF, COA, and MSDS.
| Technical Specifications & Supply Details | |
|---|---|
| Lead Time | 7 to 60 days (depending on batch size & schedule) |
| MOQ | As per manufacturer’s batch size |
| COA | Available with every batch |
| Regulatory Dossier / DMF | Available upon request |
| Export Documentation | FSC, COA, Manufacturing License, Product Permission |
| Standards | IP, BP, USP |
| Certifications | WHO-GMP, EU-GMP, USFDA (as applicable) |
Sotagliflozin can be exported to over 30 countries across Asia, Africa, Europe, and Latin America. Flexible packaging, competitive pricing, and a verified supplier network make Pharmatradz a trusted sourcing partner for pharmaceutical companies and contract manufacturers worldwide.
The Trade Mark owner has been correctly identified under the heading Manufacturer / TM Owner as required by the Act.
Frequently Asked Questions
Sotagliflozin is used for improving blood glucose control in adults with type 1 diabetes (as an adjunct to insulin) and type 2 diabetes in some regions. It works by inhibiting both SGLT1 and SGLT2 transporters, reducing glucose absorption in the intestine and increasing glucose excretion through urine.
Sotagliflozin is made from the active ingredient sotagliflozin, a dual sodium–glucose cotransporter inhibitor that blocks SGLT1 in the gut and SGLT2 in the kidneys.
A well-known trade name for Sotagliflozin is Zynquista.
Zynquista was developed by Lexicon Pharmaceuticals in collaboration with Sanofi. In some regions, rights have been managed directly by Lexicon following partnership changes.
The generic name is sotagliflozin.
The brand name is Zynquista.
Sotagliflozin is manufactured in facilities authorized by Lexicon Pharmaceuticals and its regional partners, with production occurring in the United States and Europe depending on regulatory approvals and supply chains.
Related Products
Pioglitazone Hydrochloride
Strength:
15 mg, 30 mg, 45 mg
Form: Tablets
Reference Brands: Actos (USA)
View Details
Nateglinide
Strength:
60 mg, 120 mg, 180 mg
Form: Tablets
Reference Brands: Starlix (USA)
View Details
Miglitol
Strength:
25 mg, 50 mg, 100 mg
Form: Tablets
Reference Brands: Glyset (USA), Diastabol (EU)
View Details
Glyburide
Strength:
1.25 mg, 2.5 mg, 5 mg
Form: Tablets
Reference Brands: Diabeta (USA), Micronase (USA), Glynase PresTab (USA)
View DetailsQuick Response Guaranteed | Verified Suppliers
